drugset / Trial / NCT00495092

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

NCT00495092

RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to assess the efficacy of caffeine compared to placebo in detoxifying cocaine dependent patients. Caffeine potentiation with biperiden will be also studied. 108 with cocaine dependence will be randomized to receive caffeine (300 - 1200 mg t.i.d.) plus biperidene (8 mg b.i.d.) or caffeine (300 - 1200 mg t.i.d.) with placebo or placebo during 6 months. Primary efficacy outcomes will be 1) patient comfort assessed with abstinence symptomatology, craving for cocaine and mental status during detoxifying period, 2) study retention and 3) cocaine use. Brain dopamine system will be assessed thru IBZM-SPECT and the apomorphine test.

Timeline

Start
2005-01
Primary completion
2009-12
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Biperiden Small molecule 2 mg Oral
Subject Biperiden Small molecule 4 mg Oral
Subject Caffeine Small molecule 15 mg/kg
Subject Caffeine Small molecule 300 mg
Subject Caffeine Small molecule 1200 mg

Indications